BACKGROUND: Continuous-flow left ventricular assist devices (LVAD) are increasingly used for patients with end-stage heart failure (HF). We analyzed the effects of ventricular decompression by continuous-flow versus pulsatile-flow LVADs on myocardial structure and function in this population. METHODS AND RESULTS: Sixty-one patients who underwent LVAD implantation as bridge-to-transplant were analyzed (pulsatile-flow LVAD: group P, n=31; continuous-flow LVAD: group C, n=30). Serial echocardiograms, serum levels of brain natriuretic peptide (BNP), and extracellular matrix biomarkers (ECM) were compared between the groups. Myocardial BNP and ECM gene expression were evaluated in a subset of 18 patients. Postoperative LV ejection fraction was greater (33.2±12.6% versus 17.6±8.8%, P<0.0001) and the mitral E/E' was lower (9.9±2.6 versus 13.2±3.8, P=0.0002) in group P versus group C. Postoperative serum levels of BNP, metalloproteinases (MMP)-9, and tissue inhibitor of MMP (TIMP)-4 were significantly lower in group P compared with group C (BNP: 552.6±340.6 versus 965.4±805.7 pg/mL, P<0.01; MMP9: 309.0±220.2 versus 475.2±336.9 ng/dL, P<0.05; TIMP4: 1490.9±622.4 versus 2014.3±452.4 ng/dL, P<0.001). Myocardial gene expression of ECM markers and BNP decreased in both groups; however, expression of TIMP-4 decreased only in group P (P=0.024). CONCLUSIONS: Mechanical unloading of the failing myocardium using pulsatile devices is more effective as indicated by echocardiographic parameters of systolic and diastolic LV function as well as dynamics of BNP and ECM markers. Therefore, specific effects of pulsatile mechanical unloading on the failing myocardium may have important implications for device selection especially for the purpose of bridge-to-recovery in patients with advanced HF.
BACKGROUND: Continuous-flow left ventricular assist devices (LVAD) are increasingly used for patients with end-stage heart failure (HF). We analyzed the effects of ventricular decompression by continuous-flow versus pulsatile-flow LVADs on myocardial structure and function in this population. METHODS AND RESULTS: Sixty-one patients who underwent LVAD implantation as bridge-to-transplant were analyzed (pulsatile-flow LVAD: group P, n=31; continuous-flow LVAD: group C, n=30). Serial echocardiograms, serum levels of brain natriuretic peptide (BNP), and extracellular matrix biomarkers (ECM) were compared between the groups. Myocardial BNP and ECM gene expression were evaluated in a subset of 18 patients. Postoperative LV ejection fraction was greater (33.2±12.6% versus 17.6±8.8%, P<0.0001) and the mitral E/E' was lower (9.9±2.6 versus 13.2±3.8, P=0.0002) in group P versus group C. Postoperative serum levels of BNP, metalloproteinases (MMP)-9, and tissue inhibitor of MMP (TIMP)-4 were significantly lower in group P compared with group C (BNP: 552.6±340.6 versus 965.4±805.7 pg/mL, P<0.01; MMP9: 309.0±220.2 versus 475.2±336.9 ng/dL, P<0.05; TIMP4: 1490.9±622.4 versus 2014.3±452.4 ng/dL, P<0.001). Myocardial gene expression of ECM markers and BNP decreased in both groups; however, expression of TIMP-4 decreased only in group P (P=0.024). CONCLUSIONS: Mechanical unloading of the failing myocardium using pulsatile devices is more effective as indicated by echocardiographic parameters of systolic and diastolic LV function as well as dynamics of BNP and ECM markers. Therefore, specific effects of pulsatile mechanical unloading on the failing myocardium may have important implications for device selection especially for the purpose of bridge-to-recovery in patients with advanced HF.
Authors: E A Rose; A C Gelijns; A J Moskowitz; D F Heitjan; L W Stevenson; W Dembitsky; J W Long; D D Ascheim; A R Tierney; R G Levitan; J T Watson; P Meier; N S Ronan; P A Shapiro; R M Lazar; L W Miller; L Gupta; O H Frazier; P Desvigne-Nickens; M C Oz; V L Poirier Journal: N Engl J Med Date: 2001-11-15 Impact factor: 91.245
Authors: G M Wieselthaler; H Schima; M Hiesmayr; R Pacher; G Laufer; G P Noon; M DeBakey; E Wolner Journal: Circulation Date: 2000-02-01 Impact factor: 29.690
Authors: N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger Journal: J Am Soc Echocardiogr Date: 1989 Sep-Oct Impact factor: 5.251
Authors: B E Jaski; J C Kim; D C Naftel; J Jarcho; M R Costanzo; H J Eisen; J K Kirklin; R C Bourge Journal: J Heart Lung Transplant Date: 2001-04 Impact factor: 10.247
Authors: Wayne E Richenbacher; Yoshifumi Naka; Edward P Raines; O H Frazier; Gregory S Couper; Francis D Pagani; Laura Damme; Clifford H VanMeter; George J Magovern; Lopa Gupta; Sarah C Seemuth; Alan D Weinberg; James W Long Journal: Ann Thorac Surg Date: 2003-06 Impact factor: 4.330
Authors: Stavros G Drakos; Abdallah G Kfoury; Josef Stehlik; Craig H Selzman; Bruce B Reid; John V Terrovitis; John N Nanas; Dean Y Li Journal: Circulation Date: 2012-07-10 Impact factor: 29.690
Authors: Lauren K Truby; Lakshmi Sridharan; Raul J Flores; A Reshad Garan; Douglas Jennings; Melana Yuzefpolskaya; Koji Takeda; Hiroo Takayama; Yoshifumi Naka; Paolo C Colombo; Veli K Topkara Journal: ASAIO J Date: 2019 Mar/Apr Impact factor: 2.872
Authors: Sara C Martinez; Elisa A Bradley; Eric L Novak; Ravi Rasalingam; Ari M Cedars; Gregory A Ewald; Scott C Silvestry; Susan M Joseph Journal: Tex Heart Inst J Date: 2014-06-01
Authors: Raffay S Khan; Tomoko S Kato; Aalap Chokshi; Michael Chew; Shuiqing Yu; Christina Wu; Parvati Singh; Faisal H Cheema; Hiroo Takayama; Collette Harris; Gissette Reyes-Soffer; Ralph Knöll; Hendrik Milting; Yoshifumi Naka; Donna Mancini; P Christian Schulze Journal: Circ Heart Fail Date: 2012-02-29 Impact factor: 8.790
Authors: Veli K Topkara; A Reshad Garan; Barry Fine; Amandine F Godier-Furnémont; Alexander Breskin; Barbara Cagliostro; Melana Yuzefpolskaya; Koji Takeda; Hiroo Takayama; Donna M Mancini; Yoshifumi Naka; Paolo C Colombo Journal: Circ Heart Fail Date: 2016-07 Impact factor: 8.790
Authors: Mosi K Bennett; Wendy E Sweet; Sara Baicker-McKee; Elizabeth Looney; Kristen Karohl; Maria Mountis; W H Wilson Tang; Randall C Starling; Christine S Moravec Journal: Circ Heart Fail Date: 2014-05-19 Impact factor: 8.790
Authors: Tomoko Ichiki; John A Schirger; Brenda K Huntley; Frank V Brozovich; Joseph J Maleszewski; Sharon M Sandberg; S Jeson Sangaralingham; Soon J Park; John C Burnett Journal: J Mol Cell Cardiol Date: 2014-08-09 Impact factor: 5.000